Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement

References

• Parish HJ. A History of Immunization. E and S Livingstone Ltd, Edinburgh/London, UK (1965).
   Google Scholar
• Weisser K, Hechler U. Animal Welfare Aspects in the Quality Control of Immunobiologicals. A Critical Evaluation of Animal Tests in Pharmacopoeial Monographs. FRAME, London/Nottingham, UK (1997).
   Google Scholar
• Hendriksen C, Spieser J-M, Akkermans A et al. Validation of alternative methods for potency testing of vaccines. ATLA26, 747–761 (1998).
   Google Scholar
• Ehrlich P. Die Wehrtbemessung des Diphtherieheilserum und deren theoretische Grundlage (assessing the potency of the diphtheria serum and its theoretical foundations). Klin. JahrbuchVI, 299 (1897).
   Google Scholar
• Prigge R. Experimentelle Untersuchungen über die Wirksamkeit von Diphtherie Impfstoffen (Experimental investigations of the activity of diphtheria vaccines). Deutsch. Med. Wochenschr.39, 1478–1482 (1937).
   Google Scholar
• Aldhous P, Coghlan A, Copley J. Let the people speak. New Scientist22, 26–31 (1999).
   Google Scholar
• Russell WMS, Burch RL. Principles of Humane Experimental Technique. Methuen, London, UK (1959).
   Google Scholar
• Bruckner L, Cussler K, Halder M et al. Three Rs approaches in the quality control of inactivated rabies vaccines. The report and recommendations of ECVAM workshop 48. ATLA31(4), 429–454 (2003).
   Google Scholar
• van Straaten-van de Kapelle I, van der Gun JW, Marsman FR, Hendriksen CFM, van de Donk HJM. Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine. Biologicals25, 41–57 (1997).
   Google Scholar
• Relyveld E, Bengounia A, Huet M, Kreeftenberg JG. Antibody response of pregnant women to two different adsorbed tetanus toxoids. Vaccine9(5), 369–372 (1991).
   PubMed Web of Science ®Google Scholar
• Kreeftenberg JG. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines. Dev. Biol. Stand.65, 261–266 (1986).
   Google Scholar
• Stainer DW, Jakus CM, Sparkus JD. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids. Develop. Biol. Stand.65, 241–244 (1986).
   Google Scholar
• Knight PA, Roberts PAG. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines. Develop. Biol. Stand.65, 245–255 (1986).
   Google Scholar
• Hendriksen CFM, Gun van der JW, Marsman FR, Kreeftenberg JG. The effects of reductions in the numbers of animals used for the potency assay of the diphtheria and tetanus components of adsorbed vaccines by the methods of the European Pharmacopoeia. J. Biol. Stand.15, 353–362 (1987).
   Google Scholar
• Winsnes R, Hendriksen C, Sesardic D, Akkermans A, Daas A. Serological assays as alternatives to the Ph.Eur. challenge test for batch release of tetanus vaccines for human use. Dev. Biol. Stand.101, 277–288 (1999).
   Google Scholar
• Mussett MV, Sheffield F. A collaborative investigation of a potency assay for adsorbed tetanus vaccines based on the protection of mice from titanic paralysis. J. Biol. Stand.4, 141–148 (1976).
   Google Scholar
• Knight PA. The evaluation of the response of guinea pigs to diphtheria toxoids. J. Biol. Stand.2, 69–78 (1974).
   Google Scholar
• Wunderli PS, Dreesen DW, Miller TJ, Baer GM. The rabies peripheral challenge test: more accurate determination of vaccine potency. Vaccine24(49–50), 7115–7123 (2006).
   Google Scholar
• Hartinger J, Foltz T, Cussler K. Clinical end points during rabies vaccine control tests. ALTEX18(1), 37–40 (2001).
   Google Scholar
• Johannes S, Hartinger J, Hendriksen CF, Morton DB, Cussler K. Humane end points in the efficacy testing of swine erysipelas vaccines. ALTEX20(1), 11–15 (2003).
   Google Scholar
• Hendriksen CFM, Steen B, Visser J, Cussler K, Morton D, Streijger F. The evaluation of humane end points in pertussis vaccine potency testing. In: Humane End Points in Animal Experiments for Biomedical Research. Hendriksen CFM, Morton DB (Eds). The Royal Society Medicine Press, London, UK 106–113 (1999).
   Google Scholar
• Anon. Vaccines for veterinary use. Pharmeuropa13, 363–369 (2002).
   Google Scholar
• Winsnes R, Hendriksen C. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use. Pharmeuropa Spec. Issue Bio.2001(2), 1–92 (2000).
   Google Scholar
• Winsnes R, Sesardic D, Daas A, Behr-Gross ME. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1. Pharmeuropa Bio. (2), 35–68 (2004).
   Google Scholar
• Winsnes R, Sesardic D, Daas A, Behr-Gross ME. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 2. Pharmeuropa Bio. (1), 73–88 (2006).
   Google Scholar
• Ph.Eur. Assay of Diphtheria Vaccine (Absorbed), General Method, 2.7.6. Ph. Eur. (6th Edition). Council of Europe, Strasbourg, France (2008).
   Google Scholar
• Ph.Eur. Assay of Tetanus Vaccine (Absorbed), General Method 2.7.8. Ph. Eur. (6th Edition). Council of Europe, Strasbourg, France (2008).
   Google Scholar
• van der Ark A, van Straaten-van de Kapelle I, Olander R-M et al. The pertussis serological potency test collaborative study to evaluate replacement of the mouse protection test. Biologicals28, 105–118 (2000).
   PubMed Web of Science ®Google Scholar
• Uhlrich S. Multiplex systems for serology. Presented at: the International Conference of the European Directorate for the Quality of Medicines and HealthCare, Council of Europe of the European Directorate for the Quality of Medicines and HealthCare, Council of Europe ‘Alternatives to Animal Testing: New Approaches in the Development and Control of Biologicals’. Dubrovnik, Croatia, 23–24 April 2008 (111–114).
   Google Scholar
• Descamps J, Mary A, Rommel E, Anhoury ML, De Neys R, Duchêne M. Release potency tests of hepatitis vaccines. Develop. Biol. Stand.101, 289–294 (1999).
   Google Scholar
• Landys Chovel Cuervo M, Reyes Huerta N. Validation of an in vitro potency test for the Cuban Hepatitis B vaccine. Dev. Biol.111, 305–312 (2002).
   Google Scholar
• Rooijakkers EJ, Uittenboogaard JP, Groen J, Osterhaus AD. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing. J. Virol. Methods58(1–2), 111–119 (1996).
   PubMed Web of Science ®Google Scholar
• McCullough KC, Hendriksen CFM, Seebeck T. In vitro methods in vaccinology. In: Veterinary Vaccinology. Pastoret PP, Blancou J, Vannier P, Verschueren C (Eds). Elsevier, Amsterdam, The Netherlands 70–112 (1997).
   Google Scholar
• Piersma SJ, Leenaars MP, Guzylack-Piriou L, Summerfield A, Hendriksen CF, McCullough KC. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: selection of sensitive assay criteria. Vaccine24(16), 3076–3083 (2006).
   Google Scholar
• Bergamin F, Vincent IE, Summerfield A, McCullough KC. Essential role of antigen-presenting role of cell-derived BAFF for antibody responses. Eur. J. Immunol.37(11), 3122–3130 (2007)
   PubMed Web of Science ®Google Scholar
• Hendriksen CFM, Arciniega JL, Bruckner L et al. The consistency approach for the quality control of vaccines. Biologicals36(1), 73–77 (2008).
   PubMed Web of Science ®Google Scholar
• Hendriksen C. Reduction of numbers of animals used in the quality control of biologicals. ATLA32(Suppl. 2), 53–59 (2004).
   Google Scholar
• Metz B, Brunel F, Chamberlin C et al. The potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines. ATLA35, 323–331 (2007).
   Google Scholar
• Eichelberger M, Golding H, Hess M et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007. Vaccine26(34), 4299–4303 (2008).
   PubMed Web of Science ®Google Scholar
• Morrison LA. Vaccines against genital herpes: progress and limitations. Drugs62(8), 1119–1129 (2002).
   PubMed Web of Science ®Google Scholar
• EDQM. Proceedings of: The International Conference of the European Directorate for the Quality of Medicines and HealthCare, Council of Europe. ‘Alternatives to Animal Testing: New Approaches in the Development and Control of Biologicals’. Dubrovnik, Croatia, 23–24 April 2008.
   Google Scholar
• Balls M, Karcher W. The validation of alternative test methods. ATLA23, 884–886 (1995).
   Google Scholar
• Metz B, Hendriksen CF, Jiskoot W, Kersten GF. Reduction of animal use in human vaccine quality control. Vaccine20, 2411–2430 (2002).
   PubMed Web of Science ®Google Scholar